Drug Type Therapeutic vaccine, Dendritic cell vaccine |
Synonyms Autologous monocyte-derived DCs pulsed withEBV-associated antigen(Zhongshan Hengsai) |
Target |
Action inhibitors |
Mechanism EBV Protein inhibitors |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Epstein-Barr virus associated Nasopharyngeal Carcinoma | Phase 1 | China | 04 Dec 2023 | |
Nasopharyngeal Carcinoma | Phase 1 | China | 04 Dec 2023 | |
Epstein-Barr Virus-Related Lymphoma | Phase 1 | China | 10 Jun 2023 | |
Hematologic Neoplasms | Phase 1 | China | - | 16 Jan 2023 |
Phase 1 | 9 | lneeyoggpj(kcwiexaxaw) = qdfvpsdnbt dgzqceyumo (seupxfmuxg ) | - | 11 Dec 2023 |